key: cord-0540488-69sze1zx
authors: He, C; Lin, C; Mo, G; Xi, B; Li, A; Huang, D; Wan, Y; Chen, F; Liang, Y; Zuo, Q; Xu, W; Feng, D; Zhang, G; Han, L; Ke, C; Du, H; Huang, L
title: Rapid and Accurate Detection of SARS-CoV-2 Mutations using a Cas12a-based Sensing Platform
date: 2021-10-25
journal: nan
DOI: nan
sha: 402d580ceced3e283bd7fc7dce91a8e88e6a99c0
doc_id: 540488
cord_uid: 69sze1zx

The increasing prevalence of SARS-CoV-2 variants with spike mutations has raised concerns owing to higher transmission rates, disease severity, and escape from neutralizing antibodies. Rapid and accurate detection of SARS-CoV-2 variants provides crucial information concerning the outbreaks of SARS-CoV-2 variants and possible lines of transmission. This information is vital for infection prevention and control. We used a Cas12a-based RT-PCR combined with CRISPR on-site rapid detection system (RT-CORDS) platform to detect the key mutations in SARS-COV-2 variants, such as 69/70 deletion, N501Y, and D614G. We used type-specific CRISPR RNAs (crRNAs) to identify wild-type (crRNA-W) and mutant (crRNA-M) sequences of SARS-CoV-2. We successfully differentiated mutant variants from wild-type SARS-CoV-2 with a sensitivity of $10^{-17}$ M (approximately 6 copies/$mu$L). The assay took just 10 min with the Cas12a/crRNA reaction after a simple RT-PCR using a fluorescence reporting system. In addition, a sensitivity of $10^{-16}$ M could be achieved when lateral flow strips were used as readouts. The accuracy of RT-CORDS for SARS-CoV-2 variant detection was 100% consistent with the sequencing data. In conclusion, using the RT-CORDS platform, we accurately, sensitively, specifically, and rapidly detected SARS-CoV-2 variants. This method may be used in clinical diagnosis.

A number of severe acute respiratory syndrome coronavirus 2 (SA S-CoV-2) variants have emerged since its first outbreak in 2019 (Sanyaolu et al. 2021) . Some of these variants (termed as Alpha/Beta/Gamma/Delta), which have been reported to influence viral transmissibility, disease severity, diagnostics, and vaccine efficacy, were defined as the variants of concern (VOC) by the World Health Organization (WHO) (World Health Organization. 2021). The emergence of VOC has reported in > 190 countries and regions, and > 68% of global samples are positive for VOC (Table S1 ).

Because the spike protein mediates SA S-COV-2 entry into the host and is also a significant target of neutralizing antibodies and vaccines, some key mutations of VOC occurring in the spike protein (e.g., D614G, N501Y and 69/70 deletion) have garnered significant scientific attention (Harvey et al. 2021; Salvatori et al. 2020 ). D614G, one of the key mutations, is a nonsynonymous amino acid change in the spike protein due to a 23,403 A>G single-base substitution in the SA S-CoV-2 reference sequence; the mutation was first identified in early 2020 (Korber et al. 2020 ). It is found in four SA S-CoV-2 VOC: B.1.1.7, P1, P1.351, and B.1.617.2. Patients with G614 COVID-19 show higher viral loads and 61% higher mortality than those with COVID-19 due to pre-existing variants (Davies et al. 2021a; Davies et al. 2021b; Korber et al. 2020; Plante et al. 2020 ). In addition, D614G variants have been demonstrated to increase the transmissibility in in vitro human cell models (from 1.3 to 7.7 folds) and in vivo animal models. The D614G mutation may alter proteolytic cleavage and further increase S1 shedding, or it could enhance the binding affinity between BD and AEC2 (Daniloski et al. 2021; Hou et al. 2020; Plante et al. 2020 ; Wang et al. 2021a; Zhang et al. 2020) .

N501Y is also a nonsynonymous amino acid change due to 23,063 A>T substitution in the 3 SA S-CoV-2 reference sequence. This mutation is identified in various VOC such as P1, B.1.1.7, and B.1.351 lineages. Clinical data indicate that N501Y-positive VOC significantly increase the risks of hospitalization (59% higher), intensive care unit admission (105% higher), and death (61% higher) (Fisman and Tuite 2021) . ecent evidence indicates that the N501Y mutation enhances the affinity to bind with the host angiotensin-converting enzyme 2 (ACE2) receptor by up to 7-fold more than that of the wild-type (WT) (Ali et al. 2021; Laffeber et al. 2021; Li et al. 2021b; Liu et al. 2021 ) and also enhances viral transmission both in vivo (1.0-5.3 fold) and in vitro (1.3-5.4 fold) . Furthermore, the N501Y mutation exhibits poorer binding potential for 82.7% of the common alleles of the major histocompatibility complex than N501 and might escape immune defenses (Castro et al. 2021) . The 69/70 deletion results from 204-209del in the S gene and has been found in both B.1.1.7 and B.1.526.1 variants. This small deletion is associated with the S-gene target failure of a three-target reverse transcription polymerase chain reaction ( T-PC ) assay (Bal et al. 2021) . ecently, a 2-fold increase in pseudovirus infectivity of 69/70 deletion was observed in several cell models of ACE2 expression (Meng et al. 2021a ).

Therefore, owing to the prominent impacts on viral transmissibility and disease severity, SA S-CoV-2 VOC or other variants with key mutations should be monitored and identified for enhanced epidemic control and improved clinical therapy.

Until now, sequencing has been the gold standard for identifying SA S-CoV-2 variant mutations. This method is accurate but time-consuming and costly and must be performed off-site.

Moreover, quantitative T-PC ( T-qPC ) has been developed as a gold standard for detection of SA S-CoV-2 infection, identification of SA S-CoV-2 mutations with mutation-matched primers or probes, and identification through amplification and melting curve analyses (Aoki et al. 2021; Bedotto et al. 2021; Vega-Magaña et al. 2021; Zelyas et al. 2021) . However, primer/probe mismatches in a qPC may only slightly alter these curves (Boyle et al. 2009; Stadhouders et al. 2010; Süß et al. 2009 ). Thus, the PC -based identification of single-base mutations is nonspecific and not sufficiently reliable. In addition, performing quantitative T-PC assays requires professional operations and bulky instruments.

Cas12/cr NA method, which is different from the traditional nucleic acid detection methods, recognizes targets highly specifically with only 18-20-nt cr NA; this method has been widely 4 used for the rapid diagnosis of various viruses such as African swine fever virus (AFSV), hepatitis B virus (HBV), and SA S-CoV-2 (Bai et al. 2019; Ding et al. 2021; Ma et al. 2021; Wang et al. 2021b ). By introducing an additive mismatch in cr NA, the C ISP /Cas12 system can even be used for single-nucleotide polymorphism (SNP) genotyping with single-base specificity Huang et al. 2021; Lee et al. 2020; Lee Yu et al. 2021; Meng et al. 2021b) . The identification of a single base makes Cas12 an ideal approach for mutation detection. Therefore, we assessed the detection of SA S-COV-2 mutations of concern (69/70 deletion, N501Y, and D614G) using an improved Cas12a-based C ISP on-site rapid detection system (CO DS) platform-a rapid, sensitive, and specific on-site biosensing system developed in our laboratory. We designed and screened mutant (MT)-specific cr NA (cr NA-M). Cas12/cr NA-M could specifically and rapidly differentiate SA S-CoV-2 mutations compared with WT-specific cr NA (cr NA-W). The sensitivity was 10 −17 M (6 copies/μL) with a fluorescence reporting system and up to 10 −16 M (60 copies/μL) using a lateral flow strip reporting system. The accuracy of T-CO DS is 100% consistent with that of the sequencing method. These findings indicate that the improved T-CO DS platform is a powerful tool for monitoring the key mutations in VOC and other SA S-CoV-2 variants. 

We designed the cr NAs for mutation identification based on a previous study (Bai et al. 2019 ). In brief, an 18-nt sequence following the protospacer adjacent motif (PAM; TTTV), which covers the mutation, was selected as the cr NA. In addition, as a single-base mutation of D614G and N501Y, an additional mismatch was introduced in the seed region of their cr NA-W and cr NA-M to enhance the differentiability between the WT and MT variants (Table S2 ). For the 69/70 target, TTC was selected as the PAM and no additional mismatch was introduced to the cr NA-W/M because this mutation was small deletion instead of single-base substitution (Table   S2 ).

cr NA transcription templates were prepared using 60-nt oligos containing a T7 promoter, scaffold (Table S3 ). After oligo-F and oligo-annealing, the annealed products were ligated to T-vectors to obtain pGM-T-cr NA plasmids. Finally, transcription templates were obtained through PC amplification with Pfu DNA polymerase from pGM-T-cr NA and were purified using a Gel Extraction Kit.

In vitro transcription of cr NAs used a HiScribe T7 High-Yield NA Synthesis Kit. eactions were performed in 20 μL volume at 37℃ for 16 h following the manufacturer's instruction for short NA transcripts. Finally, the cr NA transcripts were treated and purified with an NA Cleanup Kit.

The DNA targets of WT S gene and MT SA S-CoV-2 (covering D614G, N501Y and 69/70 deletion sites) were synthesized (Table S4 ) and then cloned into pUC57 plasmid.

NA targets were prepared through in vitro transcription with a HiScribe T7 High-Yield NA Synthesis Kit. Briefly, NA transcription templates containing a T7 promoter were amplified from pUC57-WT-DNA and pUC57-MT-DNA with specific primers (Table S2 ) using the NEBNext Q5 Hot Start HiFi PC Master Mix according to manufacturer's instruction, followed by purification using a Gel Extraction Kit. In vitro transcription was performed in 20 μL reaction volume, according to a standard NA synthesis protocol, at 37℃ for 16 h. Finally, NA transcripts were treated with DNaseI to remove transcription templates, purified with an NA 6 Cleanup Kit, and quantified using Thermo Fisher Nanodrop 1000 Spectrophotom.

Briefly, LbCas12a-mediated target cleavage assays were performed in 20 μL reaction volume with 50 nM LbCas12a protein, 100 nM cr NA, 1× NEBuffer2.1, 20 U recombination Nase inhibitor ( I), 5 nM linear pUC57-WT-DNA or pUC57-MT-DNA plasmids, and nuclease-free water. LbCas12a was preincubated with cr NA and I in NEBuffer2.1 at room temperature for 10 min to form ribonucleoproteins. Target DNA was then added, and the reaction mixture was incubated at 37℃ for 1 or 2 h. Finally, cleaved products were verified using gel electrophoresis.

Bioinformatic alignment of multiple SA S-CoV-2 sequences downloaded from GISAID was performed to identify specific and relatively conserved sequences adjacent to mutations. These sequences were used to design PC / T-PC primers (TableS2).

The modified CO DS fluorescence assay comprises two steps, PC amplification and Cas12a

sensing. PC reactions were performed in 50 μL reaction volume containing 20 μL of DNA, 4 μL of 10 μM primer F/ mix, 25 μL of 2× PrimeSTA max, and nuclease-free water. Thermal cycling was as follows: 3 min at 98℃ for initial denaturation; 30 cycles of 10 s at 98℃ for denaturation, 10 s at 55℃ for annealing, and 5 s at 72℃ for extension; and 5 min at 72℃ for the final extension. For Cas12a reaction, FAM-and BHQ-labeled 12-nt ssDNA reporter (FQ-ssDNA) (FAM-NNNNNNNNNNNN-BHQ) for reporting the collateral cleavage of Cas12a was synthesized. The fluorescence reporting assay was performed following a detection protocol. The whole 20 μL reaction volume contained 50 nM LbCas12a, 100 nM cr NA, and 20 U Nase inhibitor, 1× NEBuffer2.1, 10 μL PC product, 500 nM FQ-ssDNA, and nuclease-free water at room temperature. The reaction mixture was then quickly transferred to a 384-well fluorescence plate reader and incubated at 37℃. Fluorescence signals were detected using Tecan's Spark 20M multimode microplate reader at an excitation wavelength of 485 nm and an emission wavelength of 535 nm. Fluorescence assay kinetics assay were assessed with signals collected every 2.5 or 5 min.

The PC reaction for the CO DS lateral flow strip assay was performed as described earlier in this section. Digoxin-and biotin-labeled 14-nt ssDNA reporter (DB-ssDNA) (Digoxin-NNNNNNNNNNNNNN-Biotin) was used to report Cas12a collateral activity in the lateral flow strip reporting assay. Briefly, a Cas12a paper strip assay was performed in 40 μL reaction volume containing nuclease-free water, 1× NEBuffer2.1, 40 U Nase inhibitor, 50 nM LbCas12a, 100 nM cr NA, 2 nM DB-ssDNA, and 20 μL PC product. The reaction mixture was then incubated at 37℃ for 60 min. Finally, lateral flow strips were inserted into the reaction mixture and incubated at room temperature for 5 min for use as readouts.

The T-CO DS fluorescence assay comprises an T-PC reaction for amplification and a

Cas12a reaction for sensing. A One-

Step T-PC Kit was used. In brief, 50μL reaction volume contains 18.5 μL of NA sample, 4 μL of 10 μM primer F/ mix, 25 μL of 2× One

Step mix and 2.5 μL of One Step Enzyme mix. The amplification program was as follows: 30 min at 50°C for reverse transcription; 3 min at 94°C for initial denaturation; 30 cycles of 30 s at 94°C for denaturation, 30 s at 55°C for annealing, and 30 s at 72℃ for extension; and 5 min at 72 ℃ for the final extension. The Cas12a reaction was performed using a method similar to that used for the CO DS fluorescence assay, except the T-PC product substituted the PC product.

The T-PC reaction for the T-CO DS lateral strip assay was performed as described earlier in this section. The Cas12a reaction was performed using a method similar to that used for the CO DS lateral flow strip assay, except the T-PC product substituted the PC product.

NA samples of 18 SA S-CoV-2 variants were collected from Guangdong Provincial Center for Disease Control and Prevention (CDC) and treated in strict accordance with the WHO-recommended procedure and were used in the T-CO DS assay to detect real SA S-CoV-2 variants. All samples with N501Y, D614G, and 69/70 deletion mutations were detected. T-PC products of the samples were also sequenced for further validation. 

We lyophilized the Cas12a lateral flow strip reporting system to simplify the detection system for operation and production. The lyophilized system comprises two tubes: W and M. The W-tube contains NEBuffer2.1, Nase inhibitor, Cas12a, cr NA-W, and ssDNA DB reporters. This mixture was prefrozen at −80℃ for 12 h and freeze-dried at −50℃ for 4 h. The M-tube contains cr NA-M freeze-dried following the abovementioned process.

The lyophilized assay was performed by simply redissolving W-and M-tube contents in 20 μL nuclease-free water and then adding 20 μL T-PC products at room temperature. eactions are then performed as described above. Finally, lateral flow strips are inserted into the reaction mixture and incubated at room temperature for use as readouts.

All the replicate experiments in this study consisted of three repeats. Uncertainties in mean values are provided as standard errors. Statistical analyses were performed using GraphPad Prism.

Statistical significance was assessed using 2-way analysis of variance and multiple comparisons.

Significance was considered at *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; ns indicates no significance.

The SA S-CoV-2 reference genome sequence was downloaded from the National Center for Biotechnology Information and mutation information for SA S-CoV-2 variants was obtained from GISAID (https://www.gisaid.org/). Because C ISP /Cas12a has been reported to differentiate SNPs with single-base resolution Lee Yu et al. 2021; Li et al. 2018 ),

we used Cas12a to identify SA S-CoV-2 N501Y, D614G, and 69/70 deletion mutations; these are the key mutations of SA S-CoV-2 VOC (Table S1 ). These mutations are associated with transmissibility and clinical characteristics of SA S-CoV-2 variants (Hou et al. 2020; Laffeber et al. 2021; Meng et al. 2021a) . We synthesized cr NA-W and cr NA-M to target WT and MT 9 sequences for each mutation and performed in vitro cleavage assays to verify the ability of the C ISP /Cas12a system to identify SA S-CoV-2 mutations (Table S1 , Figs. 1A -1D).

We designed 501-cr NA-W (N501-WT-specific cr NA) and 501-cr NA-M (Y501-MT-specific cr NA) to detect N501Y mutation (Table S2 ). The kinetic profiling of single and double mismatches between the cr NA and target (Jones et al. 2021) , suggested the introduction of a skillful mismatch to the seed region of both 501-cr NA-W and 501-cr NA-M that make MTs easier to differentiate from WTs. As expected, we found that N501-WT substrate was significantly cleaved in the presence of 501-cr NA-W, but no cleavage was observed in the presence of 501-cr NA-M. Likewise, the 501-MT substrate was cleaved significantly by 501-cr NA-M compared with 501-cr NA-W (Fig. 1B) . The abovementioned findings indicate that 501-cr NA-W and 501-cr NA-M can identify N501Y MT variants specifically.

We also introduced a skillful mismatch into the seed region of 614-cr NA-W and 614-cr NA-M for D614G. The targets were respectively recognized and cleaved specifically and efficiently by 614-cr NA-W and 614-cr NA-M (Fig. 1C) . However, no canonical PAM TTTV motif was present adjacent to the 69/70 mutation site. We selected TTC as the PAM for LbCas12a recognition (Table S2) 

We have previously established a CO DS platform for in vitro virus nucleic acid detection (Bai et al. 2019) . For mutation identification, we also introduced fluorescence probes, 12-nt ssDNAs labeled with 5′ -FAM and 3′-BHQ, to report the collateral activity of Cas12a. We assessed the specificity of mutation discrimination by integrating a fluorescence reporter system.

Fluorescence increased solely when 501-cr NA-M was used to detect Y501-MT substrate (Fig.   1E , S1A, and S1B). The same results were observed when the substrate was N501-WT, 69/70-WT, or 69/70-MT (Figs. 1F, 1G, and S1C-S1F After validating the Cas12a fluorescence assay to differentiate mutations, we introduced PC amplification to improve the sensitivity of mutation identification. The limit of detection (LOD)

can reach 10 -16 M when Y501-MT or N501-WT amplicons serve as substrates (Figs. 2A, S2, S4A, and S4B). The 69/70 deletion can be identified even when substrate is present at 10 -17 M using TTC as the PAM (Figs. 2B, and S3) . Thus, we developed CO DS fluorescence reporting system that rapidly detects mutations from SA S-CoV-2 variants, with high sensitivity and specificity.

The system was made more convenient with reduced dependence of instruments when we combined CO DS with lateral flow strips as a substitute for the fluorescence intensity readout (Fig. 2C) . In this assay, 5′-digoxin and 3′-biotin-labeled 14-nt ssDNA and lateral flow strips were used to report the collateral activity of Cas12a (Fig. 2C) . Similar to the fluorescence reporting assay, we detected serial concentrations of substrate to determine the sensitivity of the CO DS lateral flow strips reporting system. esults indicated that LOD can reached 10 −15 M with Y501-MT or N501-WT as the substrate (Fig. 2D and S4C ). This sensitivity can also be achieved for 69/70-MT as the substrate (Fig. 2E ). CO DS paper strips system can rapidly detect SA S-CoV-2 variants mutations, with high sensitivity and without the need for a signal detection instrument.

The established CO DS fluorescence and paper strip systems can be used for rapid and sensitive detection of SA S-CoV-2 mutations with DNA targets reversely transcribed from SA S-CoV-2 NA. 

In T-CO DS, T-PC was introduced for NA reverse transcription and amplification instead of isothermal amplification because the latter is always unstable when combined with reverse transcription (Fig.S5 ). LOD reached 10 −17 M with Y501-MT NA as substrate (Figs. 3A, 15 3B). The sensitivity of the T-CO DS fluorescence reporting system was higher than that of the CO DS system, perhaps because of the different amplification ability of the DNA polymerase.

The sensitivity of T-CO DS for N501Y detection was 10 −15 M, the same sensitivity as that of CO DS, when lateral flow strips were used as final read out (Figs. 2D, 4A, and 4B) . T-CO DS fluorescence assay for 69/70 deletion identification showed a sensitivity of 10 −17 M, the same value as that achieved for N501Y (Figs. 3C and 3D ). The LOD for T-CO DS lateral flow strip was 10 −16 M ( Fig. 4C and 4D) , higher than observed for N501Y detection and in a previous study (Bai et al. 2019 ). The sensitivity for D614G Notably, kinetic analyses showed N501Y and 69/70 deletion can be identified in as small duration as 5-10 min, indicating a shorter reaction time for mutation tracking (Figs. S6 and S7). However, 40 min is the most advisable for D614G detection (Fig. S8 ). 

In total, 18 SA S-CoV-2 variant NA samples were tested using the T-CO DS paper strip system. All samples carried the D614G mutation (Fig. 5A) . Furthermore, five samples carrying the N501Y mutation and two samples carrying the 69/70 deletion were identified (Figs. 5B-5D ).

esults were 100% consistent with the sequencing data (Figs. 5, and S9-S11).

We simplified the T-CO DS procedure for storage and use through the lyophilized paper strip system (Fig. S12A) . Lyophilization did not alter the LOD for mutation identification (Fig.   S12B ). T-CO DS is a rapid, robust, and accurate method for the identification of SA S-CoV-2 N501Y, D614G, and 69/70 deletion mutations and may be used for additional tracking of spike mutations through a simple process in clinical diagnostics (Figs. 6 and S13).

DNA sequencing is the gold-standard for SA S-CoV-2 variant tracking as it can provide complete information regarding the genome sequence. However, sequencing is time-consuming, expensive and inconvenient for general laboratories. Therefore, we established the T-CO DS for SA S-CoV-2 variant tracking, which is cost-effective, rapid, specific, and sensitive. The system does not require any special laboratory equipment.

High accuracy is the key critical benefit of the T-CO DS. By introducing a skillful point mutation at the seed region of cr NA, the T-CO DS can detect the SA S-CoV-2 single-base mutations (N501Y and D614G) with high specificity. T-CO DS can also accurately identify a Fig. 6 . Detectable mutations which have been reported in spike protein of VOC and VOI by T-CO DS.

Sequences around mutations containing TTTV or TTV PAM sequence were detectable by this method.

small deletion mutation in SA S-CoV-2 (69/70 deletion) with specific cr NAs without introducing a point mutation. In this study, 18 SA S-CoV-2 variants were detected, and all three mutations identified by T-CO DS were perfectly consistent with the sequencing data, indicating 19 100% accuracy (Fig. 5) . Compared with similar C ISP -based methods, the accuracy in this study was higher than that of a Cas9-based N501Y detection method (accuracy: 86%) (Kumar et al. 2021) , and was consistent with the accuracy of a sym NA-Cas12a D614G detection method (Meng et al. 2021b) . Conversely, the accuracy of the most frequently used T-qPC for SA S-CoV-2 Marseille-4 variant detection, a point mutation in O F1, with a specific probe is 93% (Bedotto et al. 2021) . Furthermore, the ability of T-qPC to differentiate mutations distinguishment is influenced by adjacent mutations, resulting in decreased accuracy (Boudet et al. 2021; Zelyas et al. 2021) . This issue illustrates a limitation of T-qPC for variant screening.

The T-CO DS differentiates mutations in SA S-COV-2 variants accurately and exhibit high sensitivity for all three SA S-COV-2 mutation targets. T-CO DS with fluorescence showed LODs for all three mutations reached 10 -17 M (approximately 6 copies/μL) (Fig. 3) , which was higher than that of the Cas13-based N501Y detection system (100 copies/μL) (de Puig et al. 2021) and was consistent with that reported for a similar Cas12a-based D614G detection method (Huang et al. 2021; Meng et al. 2021b ). The T-CO DS with a visual readout system showed an LOD of 10 -15 M for N501Y and D614G detection and 10 -16 M for 69/70 detection (Fig. 4) . The LOD of T-CO DS for SA S-CoV-2 variant tracking was consistent with our previous study, which detected ASFV using CO DS (Bai et al. 2019 ). Thus, CO DS detection is robust and

reproducible. Clinical data reveal that viral loads of SA S-CoV-2 in throat swab and sputum samples peak around 5-6 days after symptom onset and range from 10⁴ to 10⁷ copies per mL; even higher numbers have been reported for the variants (Fajnzylber et al. 2020; Luo et al. 2021; . T-CO DS is, therefore, sufficiently sensitive to facilitate the early screening of SA S-CoV-2 variants.

The narrow range of targets makes the PAM sequences a key obstacle for designing an efficient cr NA for mutation detection. We used TTC as an alternative PAM for 69/70 deletion.

No TTTV sequence was present near the 69/70 site. Although several studies have reported a lower affinity of TTV for Cas12a loading, the LOD for the 69/70 deletion was the same as that for canonical PAM, indicating that TTV can also be efficient for activating Cas12a system sensitively ( Fig. 2B , 3C, and 4C) (Yamano et al. 2017) . Sequences adjacent to the S gene mutations of SA S-CoV-2 VOC and VOI revealed TTTV and TTV near all mutations, indicating that these 20 mutations are targetable and can be tracked using T-CO DS (Fig. 6) . Conversely, AY, a

Cas9-based SA S-CoV-2 variant tracking system, only targets a subset of mutations reported in SA S-CoV-2 variants, because no NGG PAM sequence exists near the mutation targets (Kumar et al. 2021) . Hence, T-CO DS is widely applicable for mutation tracking.

Despite the single-base resolution of Cas12, the kinetics of C ISP enzyme for molecular diagnosis recently revealed that realistic LODs for Cas13/Cas12-based detection system were only 10 pM to 100 fM, regardless of the number of targets ( amachandran and Santiago 2021). Thus, signal amplification is essential either upstream or downstream of C ISP reactions to achieve high sensitivity (Chen et al. 2020; Li et al. 2021a; Qiao et al. 2021) . Isothermal amplification such as T-PA or T-LAMP is a common choice for Cas12 based point-of-care testing (Broughton et al. 2020; Meng et al. 2021b ). However, isothermal amplification usually exhibits low efficiency and stability in mutation detection as optimal primer design is limited within the narrow range of mutant targets. Thus, we turned to conventional and stable T-PC before Cas12 sensing.

Conveniently, T-PC is also much cheaper and more available, which facilitate its use in conventional laboratory conditions.

In summary, we report that the T-CO DS is an accurate and sensitive system for identifying single-base mutations (N501Y and D614G) and a small deletion (69/70 deletion) mutation in SA S-CoV-2 variants using C ISP /Cas12a. This system is easy to assemble for SA S-COV-2 mutation screening in conventional laboratory conditions. This characteristic will be helpful for monitoring the VOC and allow the rapid tracing of epidemic trends. Although T-CO DS still relies on target amplification as many POCT methods, the high specificity and accuracy of this system make it an ideal choice for high throughput SA S-CoV-2 variant screening. 

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: three patents have been filed through South China University of Technology related to this work. 

The new SA S-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant

Development of a genotyping platform for SA S-CoV-2 variants using high-resolution melting analysis

Cas12a-Based On-Site and apid Nucleic Acid Detection of African Swine Fever

Two-step 22 strategy for the identification of SA S-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70

Implementation of an in-house real-time reverse transcription-PC assay for the rapid detection of the SA S-CoV-2 Marseille-4 variant

Limitation of Screening of Different Variants of SA S-CoV-2 by T-PC

Evaluation of the impact of single nucleotide polymorphisms and primer mismatches on quantitative PC

2020. C ISP -Cas12-based detection of SA S-CoV-2

Potential global impact of the N501Y mutation on MHC-II presentation and immune escape. bio xiv

Universal and high-fidelity DNA single nucleotide polymorphism detection based on a C ISP /Cas12a biochip

Contamination-free visual detection of SA S-CoV-2 with C ISP /Cas12a: A promising method in the point-of-care detection

The Spike D614G mutation increases SA S-CoV-2 infection of multiple human cell types

Estimated transmissibility and impact of SA S-CoV-2 lineage B.1.1.7 in England

Increased mortality in community-tested cases of SA S-CoV-2 lineage B.1.1.7

Minimally instrumented SHE LOCK (miSHE LOCK) for C ISP -based point-of-care diagnosis of SA S-CoV-2 and emerging variants

2021. C ISP /Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV

SA S-CoV-2 viral load is associated with increased disease severity and mortality

Progressive Increase in Virulence of Novel SA S-CoV-2 Variants in Ontario, Canada. med xiv : the preprint server for health sciences

CoV-2 variants, spike mutations and immune escape

D614G variant exhibits efficient replication ex vivo and transmission in vivo

2021. dsmC ISP : Dual synthetic mismatches C ISP /Cas12a-based detection of SA S-CoV-2 D614G mutation

Massively parallel kinetic profiling of natural and engineered C ISP nucleases

FnCas9 based C ISP diagnostic for rapid and accurate detection of major SA S-CoV2 variants on a paper strip

Experimental Evidence for Enhanced eceptor Binding by apidly Spreading SA S-CoV-2 Variants

2020. C ISP Diagnosis and Therapeutics with Single Base Pair Precision

Detection of rare variant alleles using the AsCas12a double-stranded DNA trans-cleavage activity

An ultrasensitive C ISP /Cas12a based electrochemical biosensor for Listeria monocytogenes detection

SA S-CoV-2 501Y.V2 26 variants lack higher infectivity but do have immune escape

C ISP -Cas12a-assisted nucleic acid detection

The N501Y spike substitution enhances SA S-CoV-2 transmission

Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals

A smartphone-based visual biosensor for C ISP -Cas powered SA S-CoV-2 diagnostics

ecurrent emergence of SA S-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Detection of the SA S-CoV-2 D614G mutation using engineered Cas12a guide NA

Viral load of SA S-CoV-2 in clinical samples

Spike mutation D614G alters SA S-CoV-2 fitness

Aptamer-locker" DNA 27 coupling with C ISP /Cas12a-guided biosensing for high-efficiency melamine analysis

SA S-CoV-2 SPIKE P OTEIN: an optimal immunological target for vaccines

The emerging SA S-CoV-2 variants of concern

The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5' nuclease assay

Studying the effect of single mismatches in primer and probe binding regions on amplification curves and quantification in real-time PC

2021. T-qPC Assays for apid Detection of the N501Y, 69-70del, K417N, and E484K

Mutations: A Screening Strategy to Identify Variants With Clinical Impact

The virological impacts of SA S-CoV-2 D614G mutation

opvC ISP : One-pot visual T-LAMP-C ISP platform for SA S-cov-2 detection

World Health Organization. 2021. Coronavirus Disease 2019 (COVID-19) Weekly Epidemiological Update 60

Structural Basis for the Canonical and Non-canonical PAM ecognition by C ISP -Cpf1

Variant of Concern by Combining Novel PC Assays and Genome Sequencing for apid Variant Detection and Surveillance

CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Identification of N501Y, D614G and 69/70 deletion target through C ISP /Cas12a trans-cleavage of fluorescence reporter with various reaction time. (A, B) Y501 and N501 identification by Cas12a/cr NA-W and cr NA-M. (C, D) G614 and D614 identification by Cas12a/cr NA-W and cr NA-M. (E, F) 69/70-MT and 69/70-WT identification by Cas12a/cr NA-W and cr NA-M. Link to Fig

A) Fluorescence kinetics of FQ-ssDNA reporter trans-cleaved by Cas12a with various Y501-MT DNA concentrations. (B to H) Sensitivity of Y501-MT detection using CO D fluorescence reporting system at different Fig. S7. Sensitivity of 69/70 deletion identification by T-CO DS fluorescence reporting assay at different reaction time